ERBB2 and neoplasm: Overexpression of the HER2 protein and/or amplification of the HER2 gene is detected in 15–20% of breast cancer tumors, leading to increased tumor cell proliferation, and is associated with aggressive tumor behavior and poor prognosis (8,9).